What's new

Human medicines European public assessment report (EPAR): Zerbaxa, ceftolozane,tazobactam, Date of authorisation: 18/09/2015, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Zerbaxa, ceftolozane,tazobactam, Date of authorisation: 18/09/2015, Revision: 16, Status: Authorised

Apr 16, 2025 - 15:53
 0
Human medicines European public assessment report (EPAR): Zerbaxa, ceftolozane,tazobactam, Date of authorisation: 18/09/2015, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Zerbaxa, ceftolozane,tazobactam, Date of authorisation: 18/09/2015, Revision: 16, Status: Authorised
Read More

Tags:

Previous Article

Kodiak Robotics to go public through SPAC

Next Article

Human medicines European public assessment report (EPAR): Pirfenidone Viatris, p...

Related Posts

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0

Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 14, 2025  0

Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 9, 2025  0